INNOCARE

09969

----

Current ValuationThe current P/E ratio is 19.66, within the reasonable range, cheaper than 57.85% of the time in the past 1 years, and the industry ranks 13/78, the industry Median -5.05.

19.66xP/E

Stock priceHK$11.77Earnings per shareHK$0.60

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0159318477636

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
02696HKHENLIUS	27.93x	28.41%	HK$27.89B
02162HKKEYMED BIO-B	27.38x	251.40%	HK$24.39B
09969HKINNOCARE	19.66x	54.29%	HK$20.80B
02157HKLEPU BIO	24.81x	127.52%	HK$7.06B
06826HKHAOHAI BIOTEC	20.41x	128.83%	HK$3.59B
06915HKJIANGXI BIO	25.31x	--	HK$2.11B
02181HKMABPHARM-B	19.25x	--	HK$1.90B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.